Maravai LifeSciences Holdings, Inc. Capital Leases, Income Statement, Amortization Expense
Maravai LifeSciences Holdings, Inc. (MRVI) reported Capital Leases, Income Statement, Amortization Expense of $1.03 million for the 3-month period ending 2021-09-30, per its 10-Q filed 2021-11-15.
Discontinued › Expense Statement › Operating Expenses
us-gaap:CapitalLeasesIncomeStatementAmortizationExpense · last filed 2021-11-15
- Maravai LifeSciences Holdings, Inc. capital leases, income statement, amortization expense for the quarter ending 2021-09-30 was $1.03M.
- Maravai LifeSciences Holdings, Inc. capital leases, income statement, amortization expense for the quarter ending 2021-06-30 was $1.05M.
- Maravai LifeSciences Holdings, Inc. capital leases, income statement, amortization expense for the quarter ending 2020-09-30 was $0.00.
- Maravai LifeSciences Holdings, Inc. capital leases, income statement, amortization expense for the quarter ending 2020-06-30 was $0.00.
| Period end | Capital Leases, Income Statement, Amortization Expense 3 month | Capital Leases, Income Statement, Amortization Expense 6 month | Capital Leases, Income Statement, Amortization Expense 9 month |
|---|---|---|---|
| 2021-09-30 | $1.03M 10-Q · filed 2021-11-15 | $2.08M derived: sum of 2 quarters · filed 2021-11-15 | $2.08M 10-Q · filed 2021-11-15 |
| 2021-06-30 | $1.05M 10-Q · filed 2021-08-11 | $1.05M 10-Q · filed 2021-08-11 | |
| 2020-09-30 | $0.00 10-Q · filed 2021-11-15 | $0.00 derived: sum of 2 quarters · filed 2021-11-15 | $0.00 10-Q · filed 2021-11-15 |
| 2020-06-30 | $0.00 10-Q · filed 2021-08-11 | $0.00 10-Q · filed 2021-08-11 |